📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: NXT-Dx

1.1 - Company Overview

NXT-Dx Logo

NXT-Dx

Headquarter: Belgium
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of epigenetics services from a private company led by an experienced team combining skills in epigenetics, transcriptomics, proteomics, and bioinformatics research.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to NXT-Dx

Tome Biosciences Logo

Tome Biosciences

HQ: United States Website
  • Description: Provider of programmable gene insertion technologies, including Integrase-Mediated PGI using a proprietary integrase to integrate large DNA sequences (>1,000 bp) at user-defined genomic locations and Ligase-Mediated PGI using a DNA ligase for small sequence insertion, plus integrative gene therapies for PKU (PAH), ASCVD (ApoA-1), HCU (CBS), and hereditary hemochromatosis (HFE).
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Tome Biosciences company profile →
ChromaCode Logo

ChromaCode

HQ: United States Website
  • Description: Provider of HDPCR-based molecular diagnostics and bioinformatics solutions for tumor profiling, minimal residual disease detection, and decentralized disease monitoring, paired with cloud software for automated interpretation, remote analysis, and scalable deployment; offerings include a multiplexed NSCLC panel delivering results in 24 hours with high concordance to NGS.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full ChromaCode company profile →
BioFluidica Logo

BioFluidica

HQ: United States Website
  • Description: Provider of a biotechnology diagnostic platform and automated liquid biopsy microfluidic system to isolate and enrich rare biomarkers—circulating tumor cells, exosomes, and trophoblasts—from body fluids; offers exosome and CTC isolation for research and cbNIPT, plus the B³ Blood Collection Tube for room-temperature whole blood shipping with buffer to inhibit micro-clotting.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full BioFluidica company profile →
Genable Technologies Logo

Genable Technologies

HQ: Ireland Website
  • Description: Provider of gene medicines to treat "dominant" genetic diseases, developed by a privately held, venture backed, Dublin (Ireland) based bio-pharmaceutical company, based on the pioneering work of Professor Jane Farrar, Dr Paul Kenna & Professor Peter Humphries.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Genable Technologies company profile →
Genomics Logo

Genomics

HQ: United Kingdom Website
  • Description: Provider of health-tech solutions leveraging genetic data to estimate disease risk, enable early detection, and support drug discovery.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Genomics company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for NXT-Dx

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to NXT-Dx

2.2 - Growth funds investing in similar companies to NXT-Dx

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for NXT-Dx

4.2 - Public trading comparable groups for NXT-Dx

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to NXT-Dx

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About NXT-Dx

What does NXT-Dx do?

NXT-Dx is a provider of epigenetics services from a private company led by an experienced team combining skills in epigenetics, transcriptomics, proteomics, and bioinformatics research.

Who are NXT-Dx's competitors?

NXT-Dx's competitors and similar companies include Tome Biosciences, ChromaCode, BioFluidica, Genable Technologies, and Genomics.

Where is NXT-Dx headquartered?

NXT-Dx is headquartered in Belgium.

How many employees does NXT-Dx have?

NXT-Dx has 1,000 employees 🔒.

When was NXT-Dx founded?

NXT-Dx was founded in 2010 🔒.

What sector and industry vertical is NXT-Dx in?

NXT-Dx is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for NXT-Dx

Who are the top strategic acquirers in NXT-Dx's sector and industry

Top strategic M&A buyers and acquirers in NXT-Dx's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for NXT-Dx?

Top strategic M&A buyers groups and sectors for NXT-Dx include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in NXT-Dx's sector and industry vertical

Which are the top PE firms investing in NXT-Dx's sector and industry vertical?

Top PE firms investing in NXT-Dx's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in NXT-Dx's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in NXT-Dx's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in NXT-Dx's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to NXT-Dx include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in NXT-Dx's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for NXT-Dx?

The key public trading comparables and valuation benchmarks for NXT-Dx include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for NXT-Dx for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for NXT-Dx with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in NXT-Dx's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for NXT-Dx with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in NXT-Dx's' sector and industry vertical?

Access recent funding rounds and capital raises in NXT-Dx's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for NXT-Dx